During the past decade, Northern Cancer Institute conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Cancer Institute" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Pfizer" with 5 trials sponsored, "Bayer" with 4 trials sponsored, "Clovis Oncology, Inc." with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Cancer Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Northern Cancer Institute" are "Colorectal Cancer" (3 trials), "Neoplasms" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Castration Resistant Prostate Cancer" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Northern Cancer Institute" in a lesser frequency.

Most popular intervention types in "Northern Cancer Institute" are "Drug" (28 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (6 trials), "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Placebo" (4 trials) and "Alectinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northern Cancer Institute" are 23 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Cancer Institute". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Northern Cancer Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Cancer Institute, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Northern Cancer Institute has several departments that took part in Clinical trials: "East Coast Cancer Centre" - 9 trials, "GenesisCare Bundaberg" - 4 trials, "Northern Cancer Institute" - 2 trials, "Adelaide Cardiology" - 3 trials, "HeartCare Partners Clinical Research Unit" - 2 trials, "GenesisCare Ringwood" - 2 trials, "Fiona Stanley Hospital - Medical Oncology" - 2 trials, "GenesisCare Wesley" - 2 trials, "GenesisCare Leabrook" - 2 trials, "Genesis Cancer Care Newcastle" - 2 trials, "GenesisCare" - 2 trials, "Adelaide Radiotherapy Centre" - 2 trials, "GenesisCare - Wexford Medical Centre WA" - 2 trials